Silva Paul M
SEC insider (Form 3/4/5 filer). CIK 0001446372. Director at Rapport Therapeutics, Inc. (RAPP) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in BOSTON, MA.
Companies Silva Paul M has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Director
- Nurix Therapeutics, Inc. (NRIX): Director
Silva Paul M
CIK: 0001446372
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 22, 2026RAPP
Rapport Therapeutics, Inc.
PurchaseIndirect3.7K shares at avg. $27.07$100K - Jun 10, 2026RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
15.2K shares- - May 15, 2026NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
31.3K shares- - Jun 17, 2025RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
10.9K shares- - May 19, 2025NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
25K shares- - Nov 7, 2024RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
29.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 |  RAPP Rapport Therapeutics, Inc. | Purchase | 3,680 | $27.07 | $99,636 | Indirect |
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 15,200 | - | - | Direct |
| May 15, 2026 |  NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 31,250 | - | - | Direct |
| Jun 17, 2025 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 10,925 | - | - | Direct |
| May 19, 2025 | NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 25,000 | - | - | Direct |
| Nov 7, 2024 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 29,756 | - | - | Direct |
1-6 of 6 transactions